ArticleResearch and reports in urology2026
The Innovex RS Delivery Catheter as a Single-Platform Endoscopic System for Upper Urinary Tract Intervention: A Two-Case Report of Upper Ureteral Lithotripsy and Ablation of a Suspected Renal Pelvis Urothelial Lesion.
Article in Research and reports in urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Conventional upper urinary tract endoscopy requires two instruments-a rigid ureteroscope for initial access and a flexible ureteroscope for intraluminal treatment-resulting in intraoperative scope exchange and dual-tower dependency. The Innovex RS delivery catheter is a rigid stainless-steel sheath that enables a single-use 7.5 Fr flexible ureteroscope to function in both rigid and flexible operative modes from one platform. To our knowledge this is the first report of a rigid-delivery sheath system used as the sole endoscopic instrument across two distinct upper urinary tract indications, and the first describing its use for ablation of a renal pelvis lesion. Cases: Two patients underwent upper urinary tract endoscopy using the RS catheter as the sole instrument: a 53-year-old male with a 12 mm impacted proximal ureteral stone (holmium:YAG lithotripsy), and a 76-year-old female with a 10 mm renal pelvis filling defect, radiologically suspected to represent urothelial pathology on the basis of CT attenuation, who underwent cold-cup biopsy followed by thulium:YAG ablation. No rigid ureteroscope, tower switching, or fluoroscopic guidance was used in either case; this reflected operator judgement rather than any intrinsic capability of the device. Results: Stone-free status was confirmed by non-contrast computed tomography on postoperative day 1 in Case 1. Macroscopic complete ablation was achieved in Case 2. Histopathological examination of the biopsy specimen demonstrated inflammatory exudate with focal urothelial mucosa and mild epithelial atypia, without definitive invasive malignancy. The ablated lesion therefore remains a radiologically suspected but histopathologically unconfirmed urothelial neoplasm, and the patient has entered a structured surveillance programme. Operative times were 55 and 90 minutes respectively; in Case 2, approximately 60 of the 90 minutes were attributable to intrapelvic clot evacuation. Clavien-Dindo grades were 0 and I respectively. Conclusion: The RS delivery catheter system enabled single-platform, single-tower ureteroscopy without scope exchange in two patients. These proof-of-concept observations establish technical feasibility only. They are not sufficient to demonstrate superiority, equivalent efficacy, improved safety, or cost-effectiveness relative to the conventional two-instrument workflow, and any such advantages remain hypotheses requiring prospective comparative evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.